Skip to main content

Female Urethral & Periurethral Masses

Female urethral and periurethral masses include benign cystic lesions, benign solid tumors, urethral mucosal lesions, urethral diverticula, and rare malignancies. They are diagnostically tricky because symptoms overlap: recurrent UTI, dysuria, dyspareunia, post-void dribbling, urethral bleeding, vaginal discharge, obstructive voiding, incontinence, and "anterior vaginal wall mass" can all describe different pathologies.[1][2]

The practical frame is: most lesions are benign, but malignancy must stay in the differential. In surgical series, malignancy ranges from about 1.6% to 6%, and unexpected malignancy may be found in urethral diverticulum specimens.[3][4][18]

Epidemiology and Etiology​

The dominant etiologies are urethral diverticulum, Skene gland cyst / abscess, urethral caruncle, and other periurethral cysts.[3][5]

LesionTypical locationClue
Urethral diverticulumPosterior / posterolateral periurethral tissue, often mid-urethralCommunicates with urethra; post-void dribbling, recurrent UTI, dyspareunia, expressible discharge
Skene gland cyst / abscessDistal paraurethral glands flanking the meatusAnterolateral distal periurethral mass; pain or purulent drainage if infected
Urethral carunclePosterior lip of urethral meatusPostmenopausal, red friable meatal polyp
Urethral mucosal prolapseCircumferential meatal mucosal eversion"Doughnut" mass around central meatus
Gartner / Mullerian / inclusion cystAnterior or anterolateral vaginal wallNo urethral communication; may mimic urethral diverticulum
LeiomyomaUrethral or paraurethral smooth muscleSolid, well-defined, vascular lesion
Primary urethral carcinomaDistal or proximal urethra, sometimes within diverticulumSolid / fixed / bleeding mass, hematuria, obstructive symptoms, suspicious imaging

In a 126-patient academic series of periurethral and anterior vaginal wall masses, urethral diverticula accounted for 39.7%, Skene gland cysts / abscesses for 30.2%, leiomyoma for about 5%, and malignancy for 1.6%.[3] In a 95-patient ultrasound series, urethral diverticula accounted for 41%, paraurethral cysts 37%, leiomyomas 14%, caruncles 8%, and carcinomas 2%.[5]

Diagnostic Approach​

Start with anatomy​

The first diagnostic move is anatomic: decide whether the lesion is meatal, urethral-dependent, periurethral, or vaginal wall / paravaginal.[1][15][26][40]

FindingMost likely diagnosesNext step
Posterior meatal polypCaruncle, carcinoma mimicking caruncleTrial estrogen if classic and mild; biopsy / excise if atypical, persistent, bleeding, growing, or painful
Circumferential meatal ringUrethral prolapseEstrogen / sitz baths if mild; excise if thrombosed, necrotic, obstructing, or refractory
Anterior vaginal wall mass with expressible urethral fluidUrethral diverticulumPelvic MRI for surgical mapping; cystoscopy as needed
Distal anterolateral periurethral massSkene gland cyst / abscessMRI or ultrasound if uncertain; excision or drainage / excision if symptomatic
Solid, vascular, fixed, rapidly growing, or bleeding massLeiomyoma, carcinoma, condyloma, other tumorMRI + cystourethroscopy + biopsy
Noncommunicating anterior vaginal wall cystGartner duct, Mullerian, inclusion cystSee Vaginal Cysts & Masses

Clinical examination alone is often informative; in one series, clinical prediction matched final diagnosis in about 81% of cases.[17] The examination should include palpation of the anterior vaginal wall along the entire urethra, inspection of the meatus, attempt to express fluid or debris, cough stress testing if prolapse / mass reduction changes continence, and documentation of tenderness, fixation, bleeding, ulceration, or rapid growth.

Imaging​

MRI is the preferred modality for most complex periurethral masses because it determines whether the lesion communicates with the urethra, whether it is cystic or solid, whether there are suspicious enhancing components, and how it relates to the continence mechanism.[1][12][15][26][40] MRI is mandatory before planned diverticulectomy in most reconstructive practices.

Transvaginal or transperineal ultrasound is a useful first-line alternative when expertise is available. It can separate cystic from solid lesions, show vascularity on Doppler, and identify common masses such as diverticula, paraurethral cysts, leiomyomas, caruncles, and carcinomas.[5][17]

Cystourethroscopy and biopsy​

Cystourethroscopy helps identify diverticular ostia, intraluminal lesions, stones, mucosal irregularity, and lesions requiring biopsy. Biopsy is required for any solid, fixed, ulcerated, rapidly growing, bleeding, recurrent, or otherwise suspicious mass. All excised urethral diverticula and periurethral masses should be sent for pathologic examination.[1][18][24]

Benign Urethral and Periurethral Masses​

Urethral caruncle​

Urethral caruncle is the most common urethral mass in postmenopausal women. It is a benign polypoid outgrowth at the urethral meatus, usually from the posterior lip.[6][7]

FeaturePractical point
PresentationOften incidental; when symptomatic, pain, hematuria, bleeding, dysuria, or local irritation are common.[7]
HistologyHyperplastic urothelial / squamous lining over inflamed, edematous, vascular stroma; pseudoneoplastic stromal atypia can mimic lymphoma or sarcoma.[7][8]
Cancer mimicUrothelial carcinoma can clinically mimic caruncle; concurrent or subsequent urothelial carcinoma has been reported in caruncle series.[7][9]
Initial treatmentTopical estrogen and observation for classic, mild lesions.[1][10]
Biopsy / excision thresholdThrombosis, significant or recurrent bleeding, urinary retention, persistent pain, atypical appearance, progression, recurrence, or symptoms persisting after 1-2 months of conservative therapy.[1][7][10][11]

Urethral mucosal prolapse​

Urethral prolapse is circumferential eversion of urethral mucosa through the meatus, classically in prepubertal girls and postmenopausal women. The exam finding is a doughnut-shaped edematous mass around the central urethral opening. Mild cases are treated with topical estrogen, sitz baths, and local care; thrombosed, necrotic, obstructing, or refractory prolapse is treated surgically.[1] See Urethral Prolapse.

Urethral diverticulum​

Urethral diverticulum is the most common periurethral mass overall and is covered in detail in Urethral Diverticulum. The classic "3 Ds" - dysuria, dyspareunia, and post-void dribbling - are memorable but insensitive. More useful symptom clusters include recurrent UTI, post-void dribbling, dyspareunia, discharge, anterior vaginal wall mass, and urinary incontinence.[3][4][12][13]

MRI is the gold-standard preoperative test, with excellent sensitivity and negative predictive value in contemporary series. It maps size, number, configuration, ostium, sphincter relationship, circumferential involvement, and suspicious wall features.[14][15][16][12] Ultrasound is a cost-effective alternative when expertise is available.[5][17]

Diverticulectomy outcomes​

Transvaginal diverticulectomy with layered closure is the standard operation for symptomatic female diverticulum.[19]

OutcomeTypical range / signal
Symptom-free after surgeryAbout 69-77% in systematic and institutional series.[19][20][21]
RecurrenceAbout 4-10%; higher for complex, circumferential, recurrent, or proximal lesions.[20][23]
De novo SUIAbout 5.6-16%.[19][20][22]
Unexpected malignancyAbout 2-6% in excised specimens.[18][24]

Key surgical principles include complete sac excision, watertight urethral closure, multilayer non-overlapping closure, preservation of continence mechanism, Martius flap interposition for complex or recurrent defects, and mandatory pathology for all specimens. Distal diverticula may be candidates for marsupialization in selected cases, but this is not the default for mid-urethral or complex lesions.[18][20][22][23][24][25]

Concomitant pubovaginal sling can improve resolution of pre-existing SUI but increases retention and recurrent UTI risk, and it does not protect against de novo SUI or diverticulum recurrence. Many surgeons therefore favor staged continence treatment after diverticulectomy healing.[22]

Skene gland cysts and abscesses​

Skene glands flank the distal urethra and can form cysts or abscesses that mimic urethral diverticulum, Bartholin cyst, or anterior vaginal wall cyst. They usually present as distal anterolateral periurethral masses with pain, dyspareunia, discharge, obstructive voiding, urinary spraying, or recurrent infection.[1][3]

MRI helps confirm that the lesion does not communicate with the urethral lumen. Symptomatic cysts and abscesses are generally treated with surgical excision or drainage / excision, with low recurrence in small series.[1][3][15][26]

Other periurethral cysts​

Gartner duct cysts, Mullerian duct cysts, and dermoid / epidermal inclusion cysts can present as anterior vaginal wall or periurethral masses. The key distinction from diverticulum is absence of urethral communication. MRI is the best single modality when anatomy is uncertain.[15][26] See Vaginal Cysts & Masses.

Urethral leiomyoma​

Urethral and paraurethral leiomyomas are rare benign smooth-muscle tumors. Ultrasound typically shows a well-defined hypoechoic solid mass with Doppler blood flow.[5][27] Asymptomatic, nonobstructive lesions can be observed with imaging and cystoscopy; symptomatic or obstructing lesions are treated with transvaginal excision and generally have excellent outcomes.[28][29]

Condyloma acuminatum​

HPV-related condyloma can involve the urethral meatus or distal urethra and may appear as a hypoechoic solid mass with Doppler blood flow on ultrasound.[5] Management depends on extent, symptoms, and exclusion of dysplasia or carcinoma.

Malignant Urethral Masses​

Primary female urethral carcinoma​

Primary urethral carcinoma is extremely rare, and women often present with nonspecific symptoms: hematuria, urethral bleeding, obstructive or irritative LUTS, palpable mass, dysuria, pain, or vaginal discharge.[30][31][32][33] Diagnostic delay is common because benign urethral masses produce the same symptoms.

Female histologic subtypes include adenocarcinoma, squamous cell carcinoma, and urothelial carcinoma. Contemporary pathology reviews emphasize that adenocarcinoma, including clear cell and Skene gland-type adenocarcinoma, is particularly important in women.[30]

Poor prognostic factors include tumor size >=3 cm, stage >T2, proximal disease, nodal involvement, and adenocarcinoma histology.[30][31][34][35] Five-year overall survival across mixed-stage cohorts is roughly 41-48%, with much better outcomes for localized distal disease than for advanced proximal disease.[34][36][37]

Workup for suspected carcinoma​

NCCN v1.2026 recommends the following workup for suspected primary urethral carcinoma:[38]

  • Cystourethroscopy with examination under anesthesia.
  • TUR or transvaginal biopsy.
  • Chest imaging with X-ray or CT.
  • MRI pelvis with and without contrast for local staging.
  • Referral to a specialized center.

Treatment is stage-, location-, and histology-specific. Options include TUR / local treatment for selected superficial disease, chemoradiotherapy, urethrectomy with or without cystectomy, distal urethrectomy for selected distal tumors, systemic therapy for nodal / metastatic disease, and pelvic exenteration for selected recurrences.[38]

Carcinoma arising in urethral diverticulum​

Carcinoma arising within a urethral diverticulum is rare but high consequence. Adenocarcinoma, including clear cell adenocarcinoma, is the dominant histology. In a 90-patient diverticulectomy series, 5 patients (6%) had invasive adenocarcinoma, and intestinal metaplasia / high-grade dysplasia were identified as precursor lesions.[18] Invasive diverticular carcinoma often requires anterior pelvic exenteration with urinary diversion rather than simple diverticulectomy.[18][39]

Red Flags​

Biopsy or urgent specialist evaluation is warranted for:

  • Solid, fixed, ulcerated, friable, or rapidly enlarging lesion.
  • Hematuria, urethral bleeding, or recurrent bleeding from a presumed caruncle.
  • Persistent pain or symptoms after 1-2 months of conservative caruncle treatment.
  • Suspicious MRI findings: enhancing solid component, irregular wall thickening, restricted diffusion, invasion, or lymphadenopathy.
  • Recurrent mass after excision.
  • Urethral diverticulum with stones, firm wall, hematuria, or atypical symptoms.
  • Any excised diverticulum or periurethral mass without pathology review.

Clinical Pearls​

  • Urethral diverticulum and Skene gland cyst account for most periurethral / anterior vaginal wall masses in women.[3]
  • A meatal lesion that looks like a caruncle can still be cancer; progression, bleeding, recurrence, atypical appearance, or failure to improve should trigger biopsy.[7][9][11]
  • MRI is the best preoperative test when a lesion may communicate with the urethra or when surgery is planned.[15][26][40]
  • Asymptomatic, nonobstructive benign masses such as small leiomyomas or cysts can be observed if malignancy has been reasonably excluded.[28][2]
  • Diverticulectomy pathology is not optional: unexpected malignancy is rare but real.[18][24]

Cross-references​

References​

1. Zuo SW, Napoe GS. Evaluation and management of urethral and periurethral masses in women. Curr Opin Obstet Gynecol. 2023;35(6):517-524. doi:10.1097/GCO.0000000000000914

2. Serrell EC, McAchran SE. Urethral masses. Obstet Gynecol Clin North Am. 2021;48(3):599-616. doi:10.1016/j.ogc.2021.05.011

3. Jacox N, Yao HH, Baverstock R, Trpkov K, Carlson K. Periurethral and anterior vaginal wall masses: etiology, presentation, and treatment outcomes. Obstet Gynecol. 2022;140(5):778-783. doi:10.1097/AOG.0000000000004956

4. Blaivas JG, Flisser AJ, Bleustein CB, Panagopoulos G. Periurethral masses: etiology and diagnosis in a large series of women. Obstet Gynecol. 2004;103(5 Pt 1):842-847. doi:10.1097/01.AOG.0000124848.63750.e6

5. Yang H, Gu JJ, Jiang L, et al. Ultrasonographic imaging features of female urethral and peri-urethral masses: a retrospective study of 95 patients. Ultrasound Med Biol. 2020;46(8):1896-1907. doi:10.1016/j.ultrasmedbio.2020.03.024

6. Liu Z, Wang X, Shui W, et al. Ultrasonographic features of female urethral caruncle: a retrospective study of 20 patients. Sci Rep. 2024;14(1):17431. doi:10.1038/s41598-024-68355-1

7. Conces MR, Williamson SR, Montironi R, et al. Urethral caruncle: clinicopathologic features of 41 cases. Hum Pathol. 2012;43(9):1400-1404. doi:10.1016/j.humpath.2011.10.015

8. Young RH, Oliva E, Garcia JA, Bhan AK, Clement PB. Urethral caruncle with atypical stromal cells simulating lymphoma or sarcoma: a distinctive pseudoneoplastic lesion of females. Am J Surg Pathol. 1996;20(10):1190-1195. doi:10.1097/00000478-199610000-00003

9. Tatemichi Y, Oikawa H, Maesawa C, et al. Detection of human papillomavirus in a urothelial carcinoma mimicking urethral caruncle. Int J Urol. 2010;17(2):189-191. doi:10.1111/j.1442-2042.2009.02434.x

10. Verma V, Pradhan A. Management of urethral caruncle - a systematic review of the current literature. Eur J Obstet Gynecol Reprod Biol. 2020;248:5-8. doi:10.1016/j.ejogrb.2020.03.001

11. Bolduan JP, Farah RN. Primary urethral neoplasms: review of 30 cases. J Urol. 1981;125(2):198-200. doi:10.1016/s0022-5347(17)54965-4

12. Greenwell TJ, Spilotros M. Urethral diverticula in women. Nat Rev Urol. 2015;12(12):671-680. doi:10.1038/nrurol.2015.230

13. Barakat B, Franke K, Hijazi S, et al. Correlation between symptoms and imaging findings including pelvic floor ultrasound to improve the symptom-based diagnosis of female urethral diverticulum (CHECK-UD Study). Int Urogynecol J. 2022;33(8):2267-2274. doi:10.1007/s00192-021-04770-6

14. Pathi SD, Rahn DD, Sailors JL, et al. Utility of clinical parameters, cystourethroscopy, and magnetic resonance imaging in the preoperative diagnosis of urethral diverticula. Int Urogynecol J. 2013;24(2):319-323. doi:10.1007/s00192-012-1841-9

15. Mahfouz W, Hassan HHM, Gubbiotti M, Elbadry M, Moussa A. Does a tailored magnetic resonance imaging technique affect the surgical planning and outcomes for different cystic urethral and periurethral swellings in females? Seven years tertiary center experience. World J Urol. 2022;40(6):1587-1594. doi:10.1007/s00345-022-03973-w

16. Venkatesan AM, Oto A, Allen BC, et al. ACR Appropriateness Criteria recurrent lower urinary tract infections in females. J Am Coll Radiol. 2020;17(11S):S487-S496. doi:10.1016/j.jacr.2020.09.003

17. Touma N, Yao HH, Shamout S, et al. Peri-urethral and anterior vaginal wall masses: does radiological imaging change the predicted diagnosis? Neurourol Urodyn. 2023;42(4):746-750. doi:10.1002/nau.25147

18. Thomas AA, Rackley RR, Lee U, et al. Urethral diverticula in 90 female patients: a study with emphasis on neoplastic alterations. J Urol. 2008;180(6):2463-2467. doi:10.1016/j.juro.2008.08.040

19. Bodner-Adler B, Halpern K, Hanzal E. Surgical management of urethral diverticula in women: a systematic review. Int Urogynecol J. 2016;27(7):993-1001. doi:10.1007/s00192-015-2862-y

20. Osman NI, Mangir N, Reeves FA, et al. The modified prone jack-knife position for the excision of female urethral diverticula. Eur Urol. 2021;79(2):290-297. doi:10.1016/j.eururo.2020.11.016

21. Chen X, Ang X, Xu X, et al. Experience in conversion of symptomatic urethral diverticulum to asymptomatic status through surgery. Sci Rep. 2025;15(1):7533. doi:10.1038/s41598-025-90748-z

22. Bradley SE, Leach DA, Panza J, et al. A multicenter retrospective cohort study comparing urethral diverticulectomy with and without pubovaginal sling. Am J Obstet Gynecol. 2020;223(2):273.e1-273.e9. doi:10.1016/j.ajog.2020.06.002

23. Ko KJ, Suh YS, Kim TH, et al. Surgical outcomes of primary and recurrent female urethral diverticula. Urology. 2017;105:181-185. doi:10.1016/j.urology.2017.02.040

24. Reeves FA, Inman RD, Chapple CR. Management of symptomatic urethral diverticula in women: a single-centre experience. Eur Urol. 2014;66(1):164-172. doi:10.1016/j.eururo.2014.02.041

25. Welch EK, Dengler KL, Welgoss JA. Urethral diverticulum marsupialization with modified Spence-Duckett procedure. Urology. 2023;176:248. doi:10.1016/j.urology.2023.02.040

26. Itani M, Kielar A, Menias CO, et al. MRI of female urethra and periurethral pathologies. Int Urogynecol J. 2016;27(2):195-204. doi:10.1007/s00192-015-2790-x

27. Wu S, Min Z, Wu L, Zhang M, Wu L. A urethral leiomyoma presenting with dysuria: a rare case report. Medicine (Baltimore). 2024;103(20):e37893. doi:10.1097/MD.0000000000037893

28. Cornella JL, Larson TR, Lee RA, Magrina JF, Kammerer-Doak D. Leiomyoma of the female urethra and bladder: report of twenty-three patients and review of the literature. Am J Obstet Gynecol. 1997;176(6):1278-1285. doi:10.1016/s0002-9378(97)70346-6

29. Migliari R, Buffardi A, Mosso L. Female paraurethral leiomyoma: treatment and long-term follow-up. Int Urogynecol J. 2015;26(12):1821-1825. doi:10.1007/s00192-015-2776-8

30. Lagarde-Lenon MS, Aron M. Female urethral carcinoma: a contemporary review of the clinicopathologic features, with emphasis on the histoanatomic landmarks and potential staging issues. Hum Pathol. 2022;129:71-80. doi:10.1016/j.humpath.2022.08.003

31. Lee W, Yu J, Lee JL, Kim YS, Hong B. Clinical features and oncological outcomes of primary female urethral cancer. J Surg Oncol. 2022;125(5):907-915. doi:10.1002/jso.26790

32. Levine RL. Urethral cancer. Cancer. 1980;45 Suppl 7:1965-1972. doi:10.1002/cncr.1980.45.s7.1965

33. Dayyani F, Hoffman K, Eifel P, et al. Management of advanced primary urethral carcinomas. BJU Int. 2014;114(1):25-31. doi:10.1111/bju.12630

34. Grigsby PW, Corn BW. Localized urethral tumors in women: indications for conservative versus exenterative therapies. J Urol. 1992;147(6):1516-1520. doi:10.1016/s0022-5347(17)37614-0

35. Wang B, Nandwana D, Davis LE, et al. Clinical and histological predictors of treatment outcomes in primary urethral carcinoma. Urol Oncol. 2025. doi:10.1016/j.urolonc.2025.09.003

36. Kobayashi K, Daizumoto K, Tsujino T, et al. Clinical outcomes and clinicopathological features of primary urethral carcinoma: a multicenter retrospective study in Japan. Int J Urol. 2026;33(2):e70367. doi:10.1111/iju.70367

37. Mano R, Vertosick EA, Sarcona J, et al. Primary urethral cancer: treatment patterns and associated outcomes. BJU Int. 2020;126(3):359-366. doi:10.1111/bju.15095

38. National Comprehensive Cancer Network. Bladder Cancer. Updated 2026-03-16. https://www.nccn.org

39. Li D, Meng FH, Yang X. Female urethral diverticular carcinoma: a case report and review of the literature. Front Oncol. 2024;14:1503116. doi:10.3389/fonc.2024.1503116

40. Saidman JM, Aineseder M, Garratt J, et al. Imaging the female urethra: US and MRI in cystic and solid pathologic conditions. Radiographics. 2025;45(3):e240064. doi:10.1148/rg.240064